Advertisement
Research Article Free access | 10.1172/JCI106036
1Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014
Find articles by Ein, D. in: JCI | PubMed | Google Scholar
1Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014
Find articles by Buell, D. in: JCI | PubMed | Google Scholar
1Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014
Find articles by Fahey, J. in: JCI | PubMed | Google Scholar
Published April 1, 1969 - More info
A new heavy chain disease protein (γHCD-JM) has been characterized by antigenic and structural criteria. The protein belongs to the IgG3-subclass and is closely related to Fc-fragment of G3-immunoglobulins. The predominant N-terminal amino acid of this protein is glutamic acid in the uncyclized form, and that of another γHCD is glycine.
Studies of the N-terminal peptides indicate that the N-terminal portion of the γ3-heavy polypeptide chain is absent from the γHCD-JM. These findings rule out a process of normal heavy chain initiation and a large deletion of the Fd region as being responsible for these two heavy chain disease proteins.
The γHCD-JM is a secretory product of cells from bone marrow as shown by studies of in vitro incorporation of amino acids-14C. Bone marrow and lymph node have a population of lymphoplasmacytic cells which by immunofluorescence contain γ-heavy chain antigens in the absence of light chain antigens.
Images.